SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: Thure Meyer who wrote (1818)7/1/2001 7:55:13 PM
From: darbyred  Read Replies (1) | Respond to of 1837
 
I agree holding is probably the best strategy until at least we determine whether Barr is successful with its August introduction of its generic Prozac. Also, Duramed will have to report at the close of the quarter, giving a better picture of Cenestin sales.

I feel really foolish, I bought more Duramed Friday morning unaware of the soon to be announced "merger".